Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1F31AG090013-01
Investigating clinical risk between autoimmunity and Alzheimer’s Disease in diverse human populations
National Institutes of Health
Grant: 3U01ES032673-05S1
JAX-Gladstone, SCGE Disease Models Studies Supplement
National Institutes of Health
Grant: 5R35GM127087-03
The Evolution of Gene Regulation and Human Disease
National Institutes of Health
Grant: 5T32GM007347-08
MEDICAL SCIENTIST TRAINING PROGRAM
National Institutes of Health
Grant: 5R01NS119678-02
Allele-specific inactivation for dominant negative NEFL Mutations
Fields of Study
Keywords